The Artificial Sphincter in the Management of Urinary Incontinence Following Prostate Cancer Therapy

Speaker: Dr. Ronald Gerridzen
Original Date: Tuesday September 29, 2015
 

Join Dr. Gerridzen as he presents "The Artificial Sphincter in the Management of Urinary Incontinence Following Prostate Cancer Therapy"
 
Overview:
During this webinar, you'll learn about:

  • Prostate cancer is common and often necessitates treatment which might result in detrimental effects on urinary control and sexual function.
  • The AMS 800 artificial urinary sphincter is an ingenious device developed and refined starting in 1973.
  • It is very effective in restoring reasonably good urinary control and thus quality of life for men whose urinary control has been moderately to severely affected by their prostate cancer treatment(s).
  • This presentation will focus on the history of the device, its current format, indications for its use, pros and cons, and results.

Speaker – Dr. Ronald G. Gerridzen, MD, FRCSC, FACS

Ronald G. Gerridzen, MD, FRCSC, FACS, completed medical school at the University of Ottawa and his Urology training at the University of Ottawa, followed by a Fellowship in Urodynamics, Neurourology & Incontinence at Sunnybrook Health Sciences Centre, University of Toronto. Following a period on staff at Sunnybrook, Dr. Gerridzen returned to the Ottawa Civic Hospital to set up the regional Urodynamics laboratory. He is a senior staff Urologic Surgeon at The Ottawa Hospital and Full Professor at the Faculty of Medicine, Department of Surgery, University of Ottawa. Dr. Gerridzen was a member of the Royal College of Physicians & Surgeons of Canada Board of Examiners in Urology for 11 years. He was past President of the Canadian Urodynamics Professionals Association and Canadian Urological Association. He was Program Director for the University of Ottawa Urology Residency Training Program; Chair, Division of Urology, University of Ottawa and Chief, Division of Urology, The Ottawa Hospital. He was recipient of Canadian Urological Association Life Achievement Award in 2015.

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive